1. Home
  2. GLPG vs ABR Comparison

GLPG vs ABR Comparison

Compare GLPG & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • ABR
  • Stock Information
  • Founded
  • GLPG 1999
  • ABR 2003
  • Country
  • GLPG Belgium
  • ABR United States
  • Employees
  • GLPG N/A
  • ABR N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • ABR Real Estate Investment Trusts
  • Sector
  • GLPG Health Care
  • ABR Real Estate
  • Exchange
  • GLPG Nasdaq
  • ABR Nasdaq
  • Market Cap
  • GLPG 1.8B
  • ABR 1.9B
  • IPO Year
  • GLPG 2005
  • ABR 2004
  • Fundamental
  • Price
  • GLPG $27.87
  • ABR $10.54
  • Analyst Decision
  • GLPG Sell
  • ABR Hold
  • Analyst Count
  • GLPG 4
  • ABR 5
  • Target Price
  • GLPG $25.33
  • ABR $12.13
  • AVG Volume (30 Days)
  • GLPG 259.2K
  • ABR 3.0M
  • Earning Date
  • GLPG 07-23-2025
  • ABR 08-01-2025
  • Dividend Yield
  • GLPG N/A
  • ABR 11.85%
  • EPS Growth
  • GLPG N/A
  • ABR N/A
  • EPS
  • GLPG N/A
  • ABR 1.03
  • Revenue
  • GLPG $311,493,731.00
  • ABR $612,893,000.00
  • Revenue This Year
  • GLPG $0.78
  • ABR N/A
  • Revenue Next Year
  • GLPG N/A
  • ABR $8.40
  • P/E Ratio
  • GLPG N/A
  • ABR $9.98
  • Revenue Growth
  • GLPG 18.32
  • ABR N/A
  • 52 Week Low
  • GLPG $22.36
  • ABR $8.43
  • 52 Week High
  • GLPG $31.23
  • ABR $15.94
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 51.86
  • ABR 54.18
  • Support Level
  • GLPG $26.62
  • ABR $10.43
  • Resistance Level
  • GLPG $29.28
  • ABR $10.80
  • Average True Range (ATR)
  • GLPG 0.58
  • ABR 0.27
  • MACD
  • GLPG -0.16
  • ABR 0.07
  • Stochastic Oscillator
  • GLPG 54.51
  • ABR 66.25

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

Share on Social Networks: